Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,710.42
(
0.28%
)
News Focus
News Focus
Post# of 257267
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: efar post# 119753

Tuesday, 05/10/2011 3:15:44 PM

Tuesday, May 10, 2011 3:15:44 PM

Post# of 257267

anyone have a theory for what is behind the run?

Possibly a buyout. IDIX no longer has the scale to be a standalone drug-discovery company in the antiviral arena, so it would make sense for the company to be sold.

The founder and ex-CEO, JP Sommadossi, was never replaced; instead, the CFO simply moved into the corner office. This is exactly what happened at CEPH when the founder and CEO, Frank Baldino, died in Dec 2010; a few months later, the company was sold.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today